AbbVie
ABBV
#25
Rank
C$731.86 B
Marketcap
C$414.04
Share price
0.56%
Change (1 day)
34.90%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): C$12.16 Billion

According to AbbVie's latest financial reports the company's current earnings are C$64.38 Billion. In 2025 the company made an earning of C$9.32 Billion, an increase over its 2024 earnings that were of C$5.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$12.16 B30.51%
2025 C$9.32 B77.53%
2024 C$5.25 B-40.54%
2023 C$8.83 B-53.62%
2022 C$19.04 B3.76%
2021 C$18.35 B282.25%
2020 C$4.80 B-59.67%
2019 C$11.90 B62.13%
2018 C$7.34 B-32.74%
2017 C$10.92 B-1.99%
2016 C$11.14 B18.65%
2015 C$9.39 B180.5%
2014 C$3.34 B-55.57%
2013 C$7.53 B-6.86%
2012 C$8.09 B56.05%
2011 C$5.18 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.76 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.14 B 299.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.53 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$1.42 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.77 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.01 B 30.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.25 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$10.11 B-17.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.15 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA